Clozapine attenuates meta-chlorophenylpiperazine (mCPP)-induced plasma cortisol increases in schizophrenia
- 1 October 1993
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 34 (7) , 492-494
- https://doi.org/10.1016/0006-3223(93)90241-5
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- m-Chlorophenylpiperazine Effects in Neuroleptic-Free Schizophrenic PatientsArchives of General Psychiatry, 1993
- Effects of Clozapine and Fluphenazine Treatment on Responses to m-Chlorophenylpiperazine Infusions in SchizophreniaArchives of General Psychiatry, 1993
- Clinical and Biologic Response to Clozapine in Patients With SchizophreniaArchives of General Psychiatry, 1992
- The MCPP challenge test in schizophrenia: Hormonal and behavioral responsesBiological Psychiatry, 1991
- Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sitesEuropean Journal of Pharmacology, 1990
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- Functional Correlates of Serotonin 5-HT1Recognition SitesJournal of Receptor Research, 1988
- Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitroEuropean Journal of Pharmacology, 1987
- Typical and atypical antipsychotic occupancy of D2 and S2 receptors: An autoradiographic analysis in rat brainBrain Research Bulletin, 1986
- Radioimmunoassay of Plasma CortisolAnalytical Letters, 1972